Investigation of the Effect of Physical Activity Level on Sleep Quality and Fatigue in Academicians

NCT03841461 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-02-19

No results posted yet for this study

Summary

Physical activity is closely associated with well-being condition and health development. The sleep quality and fatigue levels of individuals are also important components of health. Within the scope of our study, it is aimed to investigate the physical activity levels, sleep quality and fatigue levels of the academicians, who are generally working on a desk and we think that they live a sedentary life. Within the scope of this study, academicians were asked to respond to , International Physical Activity Questionnaire-Short Form (IPAQ-Short Form), general evaluation form, Pittsburg Sleep Quality Index (PSQI) and Fatigue Severity Scale (FSS) .

Conditions

Interventions

OTHER

International Physical Activity Questionnaire-Short Form

IPAQ has been developed to obtain valid and comparable information about the level of physical activity based on individual reports on daily physical activity in the international arena. This form consists of 7 questions; provides information about time spent in walking, moderate and violent activities, and time spent sitting. The calculation of the total score of the short form includes total of duration and frequency whom walking, moderate activity and severe activity. The energy required for the activities is calculated by the MET-minute score.Standard MET values for these activities has been established. These; Walking = 3.3 MET;Moderate Severe Physical Activity = 4.0 MET;Severe Physical Activity = 8.0 MET;Seating = 1.5 MET.Classification is based on the numerical data obtained.Accordingly,there are 3 activity levels: Inactive,minimal active and very active.

OTHER

The Pittsburgh Sleep Quality Index

It is a scale that provides information about the sleep quality of the individuals and the type and severity of the sleep disorder in the last month. It consists of 24 questions, 19 of which are evaluated. The PSQI consists of 1 total score and 7 sub-dimensions (subjective sleep quality, sleep latency, sleep duration, usual sleep efficiency, sleep disturbance, sleep medication use, daytime dysfunction). Each item in the scale has a value between 0 (no distress) and 3 (serious distress). The sum of the scores related to the seven sub-dimensions gives the total PSQI score. The score of each sub-dimension ranges from 0 to 3. The total PSQI score ranged from 0 to 21. While the sleep quality of the patients with a total score of 5 and below is considered as 'good'; \>5 refers to poor sleep quality.

OTHER

The Fatigue Severity Scale

Each question on this scale, which is composed of Likert type questions: 1.I strongly disagree 2.I do not agree 3.No tend to disagree 4. Indefinitely. The score of the scale, which consists of 9 questions, varies between 9-63. People are asked to mark the appropriate options for each question taking into account their status in the last 1 month period.

OTHER

General Information Form

A form, which is prepared by us, including the purpose of the study, demographic information, daily working hours and assignment durations.

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    lead OTHER

Principal Investigators

  • Nazire Nur Yıldız, PT · AYBU Institute of Health Sciences Department of Physiotherapy and Rehabilitation Master Program/Master Degree Student

  • Ertuğrul Demirdel, Asst. Prof. · AYBU Faculty of Health Sciences Department of Physiotherapy and Rehabilitation

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2019-03-01
Completion
2019-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03841461 on ClinicalTrials.gov